Harbinger Health
PrivateLast Round
Series B
Extension
Apr 14, 2026
Total Funding Raised
$290M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Harbinger Health is a biotechnology company that develops AI-enabled, blood-based multi-cancer detection tests designed to identify cancer at its earliest stages.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Harbinger Health Comparables
Compare Harbinger Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adela | 89% | |
| ClearNote Health | 86% | |
| Delfi Diagnostics | 82% |
Harbinger Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 14, 2026 | ||||
| Series B | Sep 28, 2023 | ||||
| Series A | Dec 7, 2021 |
Harbinger Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pictet Group | Series B Extension, Series B |
| M&G Investments | Series B Extension, Series B |
| Partners Investment | Series B Extension, Series B |
| Flagship Pioneering | Series B Extension, Series A, Series B |
| M&G plc | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 58% MoM, reaching 4.4K.
- Apr 17, 2026
Models infer lung cancer progression from blood draw cfDNA methylation data.
Harbinger Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Harbinger Health's valuation, stock price, and market status.
Is arbinger Health a public or private company?
arbinger Health is a private company.
What is the current stock price of arbinger Health?
arbinger Health is a private company with no public stock price. No recent secondary market data is available.
How much is arbinger Health worth (valuation)?
Valuation information for arbinger Health is not publicly available.
Can I buy arbinger Health stock?
arbinger Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was arbinger Health's last funding round?
arbinger Health's most recent funding round was Series B on April 14, 2026.
Who are the main investors in arbinger Health?
Key investors in arbinger Health include Flagship Pioneering.
Will arbinger Health IPO soon?
No public IPO plans have been announced for arbinger Health.
How can I track arbinger Health secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor arbinger Health's secondary market activity and sign up for updates.